WR Grace
since Dec 2010
-
R&D ChemistWR Grace
Jun 2010 - Nov 2010
-
Postdoc Chemist
Education:
Penn State University 2005 - 2010
PhD, Polymer ChemistryUniversity of Science and Technology of China 2001 - 2005
BS, Chemistry
Interests:
Ski, swim, bike
Student At University Of Massachusetts Boston
Location:
Greater Boston Area
Industry:
Biotechnology
Education:
University of Massachusetts Boston 2007 - 2011
University of Massachusetts Boston 2007 - 2011
BS, biology, economy
Pharmaceuticals Professional
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Dr. Ying Chen, Dallas TX - MD (Doctor of Medicine)
Specialties:
Diagnostic Radiology
Address:
5201 Harry Hines Blvd, Dallas 75235 (214) 590-8000 (Phone), (214) 590-8341 (Fax) 55 Fruit St STE 216, Boston 02114 (617) 724-4255 (Phone), (617) 726-3077 (Fax)
Languages:
English
Ying Chen
Specialties:
Buyer's Agent, Listing Agent
Work:
231 Harvard Ave, Boston 02134
Mandarin Instructor And Private Tutor
Location:
Greater Boston Area
Industry:
Individual & Family Services
3-Pyridinecarboxamide Reduces Nerve Degeneration
US Patent:
2006021, Sep 21, 2006
Filed:
Dec 5, 2005
Appl. No.:
11/295647
Inventors:
Zhigang He - Boston MA, US Jing Wang - Boston MA, US Ying Chen - Boston MA, US
International Classification:
G06Q 10/00, A61K 31/455
US Classification:
514356000, 705002000
Abstract:
Neural degeneration is reduced in a patient determined to be suffering from chronic neurodegeneration by administering to the patient an effective amount of 3-pyridinecarboxamide (nicotinamide) and detecting a resultant decrease in the neural degeneration.
3-Pyridinecarboxamide Reduces Nerve Degeneration
US Patent:
2006021, Sep 21, 2006
Filed:
Mar 21, 2005
Appl. No.:
11/085948
Inventors:
Zhigang He - Boston MA, US Jing Wang - Boston MA, US Ying Chen - Boston MA, US
International Classification:
A61K 31/455, G06Q 10/00
US Classification:
514356000, 705002000
Abstract:
Neural degeneration is reduced in a patient determined to be suffering from chronic neurodegeneration by administering to the patient an effective amount of 3-pyridinecarboxamide (nicotinamide) and detecting a resultant decrease in the neural degeneration.